SELLAS Life Sciences Group, Inc. 8-K

What Happened
SELLAS Life Sciences Group, Inc. (SLS) filed an 8-K reporting the results of its Annual Meeting of Stockholders held June 16, 2026. Approximately 115,511,771 shares (about 62.59% of outstanding shares) were present or represented by proxy. Stockholders re-elected two Class I directors, ratified the appointment of Baker Tilly US, LLP as independent auditor for fiscal 2026, approved a 20,000,000-share increase to the 2023 Equity Incentive Plan, approved the advisory (non-binding) executive compensation vote, and approved an adjournment proposal to solicit additional proxies if needed.

Key Details

• Meeting attendance: 115,511,771 shares present or represented by proxy (~62.59% of outstanding).
• Director re-elections (terms to 2029):
  • Robert Van Nostrand — For: 66,490,143; Withheld: 4,544,035; Broker non-votes: 44,477,593.
  • Jane Wasman — For: 65,928,448; Withheld: 5,105,730; Broker non-votes: 44,477,593.
• Auditor ratification: Baker Tilly US, LLP ratified for fiscal year ending December 31, 2026 — For: 112,103,701; Against: 2,126,460; Abstain: 1,281,610.
• Equity plan amendment: Approved to add 20,000,000 shares to the 2023 Equity Incentive Plan — For: 42,906,271; Against: 27,310,386; Abstain: 817,521; Broker non-votes: 44,477,593.
• Say-on-pay (advisory): Approved — For: 52,930,792; Against: 15,906,732; Abstain: 2,196,654; Broker non-votes: 44,477,593.
• Adjournment (to solicit additional proxies if needed): Approved — For: 90,571,992; Against: 22,200,030; Abstain: 2,739,749.

Why It Matters
The meeting results maintain board continuity with the re-election of two directors and secure audit continuity by ratifying Baker Tilly as the independent auditor. Approval of the 20 million-share increase to the 2023 Equity Incentive Plan expands the company’s potential equity awards, which can be used for compensation and incentives but may dilute existing shareholders if issued. The advisory approval of executive compensation signals shareholder support but is non-binding. Notably, a large number of broker non-votes on several proposals indicates many shares held by brokers did not vote on those matters, which can affect vote outcomes for items requiring a majority of votes cast.